BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31953038)

  • 1. BAG3
    Robertson R; Conte TC; Dicaire MJ; Rymar VV; Sadikot AF; Bryson-Richardson RJ; Lavoie JN; O'Ferrall E; Young JC; Brais B
    Am J Pathol; 2020 Mar; 190(3):554-562. PubMed ID: 31953038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P209L mutation in Bag3 does not cause cardiomyopathy in mice.
    Fang X; Bogomolovas J; Zhou PS; Mu Y; Ma X; Chen Z; Zhang L; Zhu M; Veevers J; Ouyang K; Chen J
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H392-H399. PubMed ID: 30499714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zebrafish models of BAG3 myofibrillar myopathy suggest a toxic gain of function leading to BAG3 insufficiency.
    Ruparelia AA; Oorschot V; Vaz R; Ramm G; Bryson-Richardson RJ
    Acta Neuropathol; 2014 Dec; 128(6):821-33. PubMed ID: 25273835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BAG3 myopathy is not always associated with cardiomyopathy.
    Andersen AG; Fornander F; Schrøder HD; Krag T; Straub V; Duno M; Vissing J
    Neuromuscul Disord; 2018 Sep; 28(9):798-801. PubMed ID: 30061062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic compensation prevents myopathy and heart failure in an in vivo model of Bag3 deficiency.
    Diofano F; Weinmann K; Schneider I; Thiessen KD; Rottbauer W; Just S
    PLoS Genet; 2020 Nov; 16(11):e1009088. PubMed ID: 33137814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BAG3 myofibrillar myopathy presenting with cardiomyopathy.
    Konersman CG; Bordini BJ; Scharer G; Lawlor MW; Zangwill S; Southern JF; Amos L; Geddes GC; Kliegman R; Collins MP
    Neuromuscul Disord; 2015 May; 25(5):418-22. PubMed ID: 25728519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide Spectrum of Cardiac Phenotype in Myofibrillar Myopathy Associated With a Bcl-2-Associated Athanogene 3 Mutation: A Case Report and Literature Review.
    Akaba Y; Takeguchi R; Tanaka R; Makita Y; Kimura T; Yanagi K; Kaname T; Nishino I; Takahashi S
    J Clin Neuromuscul Dis; 2022 Sep; 24(1):49-54. PubMed ID: 36005473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin rescues muscle function in BAG3 myofibrillar myopathy models.
    Ruparelia AA; McKaige EA; Williams C; Schulze KE; Fuchs M; Oorschot V; Lacene E; Meregalli M; Lee C; Serrano RJ; Baxter EC; Monro K; Torrente Y; Ramm G; Stojkovic T; Lavoie JN; Bryson-Richardson RJ
    Autophagy; 2021 Sep; 17(9):2494-2510. PubMed ID: 33030392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAG3 mutation in a patient with atypical phenotypes of myofibrillar myopathy and Charcot-Marie-Tooth disease.
    Kim SJ; Nam SH; Kanwal S; Nam DE; Yoo DH; Chae JH; Suh YL; Chung KW; Choi BO
    Genes Genomics; 2018 Dec; 40(12):1269-1277. PubMed ID: 30145633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exome sequencing identifies variants in two genes encoding the LIM-proteins NRAP and FHL1 in an Italian patient with BAG3 myofibrillar myopathy.
    D'Avila F; Meregalli M; Lupoli S; Barcella M; Orro A; De Santis F; Sitzia C; Farini A; D'Ursi P; Erratico S; Cristofani R; Milanesi L; Braga D; Cusi D; Poletti A; Barlassina C; Torrente Y
    J Muscle Res Cell Motil; 2016 Jun; 37(3):101-15. PubMed ID: 27443559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss-of-function mutations in co-chaperone BAG3 destabilize small HSPs and cause cardiomyopathy.
    Fang X; Bogomolovas J; Wu T; Zhang W; Liu C; Veevers J; Stroud MJ; Zhang Z; Ma X; Mu Y; Lao DH; Dalton ND; Gu Y; Wang C; Wang M; Liang Y; Lange S; Ouyang K; Peterson KL; Evans SM; Chen J
    J Clin Invest; 2017 Aug; 127(8):3189-3200. PubMed ID: 28737513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation in BAG3 causes severe dominant childhood muscular dystrophy.
    Selcen D; Muntoni F; Burton BK; Pegoraro E; Sewry C; Bite AV; Engel AG
    Ann Neurol; 2009 Jan; 65(1):83-9. PubMed ID: 19085932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAG3-related myopathy, polyneuropathy and cardiomyopathy with long QT syndrome.
    Kostera-Pruszczyk A; Suszek M; Płoski R; Franaszczyk M; Potulska-Chromik A; Pruszczyk P; Sadurska E; Karolczak J; Kamińska AM; Rędowicz MJ
    J Muscle Res Cell Motil; 2015 Dec; 36(6):423-32. PubMed ID: 26545904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulated autophagy in restrictive cardiomyopathy due to Pro209Leu mutation in BAG3.
    Schänzer A; Rupp S; Gräf S; Zengeler D; Jux C; Akintürk H; Gulatz L; Mazhari N; Acker T; Van Coster R; Garvalov BK; Hahn A
    Mol Genet Metab; 2018 Mar; 123(3):388-399. PubMed ID: 29338979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAG3-related myofibrillar myopathy: a further observation with cardiomyopathy at onset in pediatric age.
    Scarpini G; Valentino ML; Giannotta M; Ragni L; Torella A; Columbaro M; Nigro V; Pini A
    Acta Myol; 2021 Dec; 40(4):177-183. PubMed ID: 35047758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of human BAG3
    Kimura K; Ooms A; Graf-Riesen K; Kuppusamy M; Unger A; Schuld J; Daerr J; Lother A; Geisen C; Hein L; Takahashi S; Li G; Röll W; Bloch W; van der Ven PFM; Linke WA; Wu SM; Huesgen PF; Höhfeld J; Fürst DO; Fleischmann BK; Hesse M
    Nat Commun; 2021 Jun; 12(1):3575. PubMed ID: 34117258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FLNC myofibrillar myopathy results from impaired autophagy and protein insufficiency.
    Ruparelia AA; Oorschot V; Ramm G; Bryson-Richardson RJ
    Hum Mol Genet; 2016 Jun; 25(11):2131-2142. PubMed ID: 26969713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 Signaling.
    Quintana MT; Parry TL; He J; Yates CC; Sidorova TN; Murray KT; Bain JR; Newgard CB; Muehlbauer MJ; Eaton SC; Hishiya A; Takayama S; Willis MS
    Am J Pathol; 2016 Aug; 186(8):1989-2007. PubMed ID: 27321750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAG3 Myopathy Presenting With Prominent Neuropathic Phenotype and No Cardiac or Respiratory Involvement: A Case Report and Literature Review.
    Malatesta L; Arya K; Gokden M; Stefans V; Veerapandiyan A
    J Clin Neuromuscul Dis; 2020 Jun; 21(4):230-239. PubMed ID: 32453099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual multisystemic involvement and a novel BAG3 mutation revealed by NGS screening in a large cohort of myofibrillar myopathies.
    Semmler AL; Sacconi S; Bach JE; Liebe C; Bürmann J; Kley RA; Ferbert A; Anderheiden R; Van den Bergh P; Martin JJ; De Jonghe P; Neuen-Jacob E; Müller O; Deschauer M; Bergmann M; Schröder JM; Vorgerd M; Schulz JB; Weis J; Kress W; Claeys KG
    Orphanet J Rare Dis; 2014 Aug; 9():121. PubMed ID: 25208129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.